Published in TB and Outbreaks Week, February 17th, 2009
Dr. Vidadi Yusibov, CMB's Executive Director said, "CMB's vaccine technology has the potential to revolutionize how vaccines are manufactured, allowing for a more rapid and affordable response to pandemic flu threats."
"It is essential that new vaccines reach the people who need...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week